A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients von ALFONSO, Sailyn, VALDES-ZAYAS, Anet, ORTIZ, Ramón A, DE LA TORRE, Ana V, CEPEDA, Meylán, PEREZ, Kirenia, CHONG, Eric, HERNANDEZ, Ana Maria, TOLEDO, Darien, GONZALEZ, Zuyén, MAZORRA, Zaima, CROMBET, Tania, SANTIESTEBAN, Eduardo R, PEREZ, Rolando, VAZQUEZ, Ana Maria, MACIAS, Amparo E, FLORES, Yoanna I, ARECES, Fernando, HERNANDEZ, Maurenis, VIADA, Carmen E, MENDOZA, Ivis C, GUERRA, Pedro P, GARCIA, Elena

Volltext

RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients von Hernandez, Maurenis, Santiesteban, Eduardo Rafael, Ortiz, Ramon Alberto, Neninger, Elia, Acosta, Soraida, Flores, Yoana, Amador, Rosa Maria, Robaina, Mayte, Mendoza, Ivis, Guerra, Pedro Pablo, Valdes, Anet, Vazquez, Ana Maria, Macias, Amparo, Crombet, Tania

Volltext

P2.40: CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients von Hernandez, Maurenis, Ortiz, Ramon A., Neninger, Elia, Amador, Rosa M., Cala, Mireisy, Camacho, Kirenia, Salomon, Eva, Guerra, Pedro P., Mendoza, Ivis, Sanchez, Carlos, Viada, Carmen, Gonzalez, Matilde, Torres, Lourdes T., Fonseca, Vivian, Garcia, Ivon, Bello, Loisel, Alonso, Maribel, Rodriguez, Maria C., Cruz, Aivin, Valdes, Rolando, Lorenzo, Geidy, Cepeda, Meylan, Saumel, Yaimarelis, Crombet, Tania

Volltext

P2.40: CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients: Track: Immunotherapy von Hernandez, Maurenis, Ortiz, Ramon A., Neninger, Elia, Amador, Rosa M., Cala, Mireisy, Camacho, Kirenia, Salomon, Eva, Guerra, Pedro P., Mendoza, Ivis, Sanchez, Carlos, Viada, Carmen, Gonzalez, Matilde, Torres, Lourdes T., Fonseca, Vivian, Garcia, Ivon, Bello, Loisel, Alonso, Maribel, Rodriguez, Maria C., Cruz, Aivin, Valdes, Rolando, Lorenzo, Geidy, Cepeda, Meylan, Saumel, Yaimarelis, Crombet, Tania

Volltext

Efficacy of nimotuzumab according to inflammatory indices in patients with advanced non-small cell lung cancer von Kirenia Camacho Sosa, Mayra Ramos Suzarte, Carmen Elena Viada González, Elia Nenínger Vinageras, Eduardo Rafael Santiesteban Álvarez, Maurenis Hernández Pérez, Yoanna Ivette Flores Vega, Saylin Alfonso Alemán, Ramón Alberto Ortiz Carrodeguas, Soraida Candida Acosta Brooks, Pedro Pablo Guerra Chaviano, Ivis Mendoza Hernández, Tania Crombet Ramos, Agustín Lage Dávila

Volltext

Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer von Santiesteban, Eduardo, Perez, Leslie, Alfonso, Sailyn, Neninger, Elia, Acosta, Soraida, Flores, Yoana, Hernandez, Maurenis, Viada, Carmen, García, Robin, Cepeda, Meylán, Estevez, Daymys, Moreno, Yoisbel, Macías, Amparo

Volltext

Eficacia del nimotuzumab según índices inflamatorios en pacientes con cáncer de pulmón no microcítico avanzado von Camacho Sosa, Kirenia, Ramos Suzarte, Mayra, Viada González, Carmen Elena, Nenínger Vinageras, Elia, Santiesteban Álvarez, Eduardo Rafael, Hernández Pérez, Maurenis, Flores Vega, Yoanna Ivette, Alfonso Alemán, Saylin, Ortiz Carrodeguas, Ramón Alberto, Acosta Brooks, Soraida Candida, Guerra Chaviano, Pedro Pablo, Mendoza Hernández, Ivis, Crombet Ramos, Tania, Lage Dávila, Agustín

Volltext